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Singlet molecular oxygen (1O2) has well-established roles in photosynthetic plants, bacteria 
and fungi1-3, but not in mammals. Chemically generated 1O2 oxidizes the amino acid 
tryptophan to precursors of a key metabolite called N-formylkynurenine4, while enzymatic 
oxidation of tryptophan to N-formylkynurenine is catalyzed by a family of dioxygenases, 
including indoleamine 2,3-dioxygenase 15. Under inflammatory conditions, this heme-
containing enzyme becomes expressed in arterial endothelial cells, where it contributes to the 
regulation of blood pressure6. However, whether indoleamine 2,3-dioxygenase 1 forms 1O2 
and whether this contributes to blood pressure control is unknown. Here we show that 
arterial indoleamine 2,3-dioxygenase 1 regulates blood pressure via formation of 1O2. We 
observed that in the presence of hydrogen peroxide, the enzyme generates 1O2 and that this is 
associated with the stereoselective oxidation of L-tryptophan to a tricyclic hydroperoxide via a 
previously unrecognized oxidative activation of the dioxygenase activity. The tryptophan-
derived hydroperoxide acts as a hitherto undiscovered signaling molecule in vivo, which 
induces arterial relaxation and decreases blood pressure dependent on cysteine residue 42 of 
protein kinase G1α . Our findings demonstrate a pathophysiological role for 1O2 in mammals 
through formation of an amino acid-derived hydroperoxide that regulates vascular tone and 
blood pressure under inflammatory conditions. 
Small molecules, such as nitric oxide and hydrogen peroxide (H2O2) regulate cellular signaling 
via interaction with proteins containing redox active metals and/or cysteine residues. Of these 
molecules, nitric oxide, formed from L-arginine by endothelial nitric oxide synthase, is an important 
regulator of vascular tone7. Sustained increases in nitric oxide synthesis by inducible nitric oxide 
synthase, as observed in pathological settings such as sepsis, are associated with profound 
hypotension8. Paradoxically, inhibitors of the nitric oxide pathway have generally failed to 
ameliorate severe septic shock9,10, suggesting involvement of additional mediators of hypotension. 
Based on functional similarity with the metabolism of L-arginine by nitric oxide synthase, we 
reported previously that metabolism of L-tryptophan (Trp) to N-formylkynurenine (NFK) and 
	 3 
kynurenine by endothelial indoleamine 2,3-dioxygenase 1 (IDO1) (Fig. 1a) contributes to the 
regulation of vascular tone and blood pressure in inflammation, and that commercial kynurenine 
relaxed pre-constricted arteries6. Although others have since confirmed these findings11,12, we 
noticed that recently purchased kynurenine no longer relaxed arteries, and that HPLC-purified 
kynurenine and NFK also failed to relax naïve mouse arteries (Extended Data, fig. 1a). However, 
purified Trp relaxed pre-constricted mouse abdominal aortas that expressed IDO1, irrespective of 
whether IDO1 expression was induced in vitro by treating arteries with interferon-γ or in vivo by 
treating mice with lipopolysaccharide6 (Extended Data, fig. 1b, c). These findings indicated that the 
‘relaxing factor’ derived from Trp is likely a metabolite ‘upstream’ of NFK and that earlier 
commercial preparations of kynurenine might have contained this molecule as a contaminant. 
As chemical oxidation of Trp by 1O2 yields products that decay to NFK4, and commercial 
kynurenine can be produced via Trp oxidation by 1O213, we exposed Trp to 1O2 in vitro. Such ‘1O2-
exposed Trp’ dose-dependently relaxed endothelium-denuded naïve abdominal aortas that do not 
express IDO1 (Fig. 1b). HPLC/UV analysis revealed ‘1O2-exposed Trp’ to contain eight distinct 
compounds (labeled Peaks 1-8, Fig. 1c). By comparison to authentic standards, Peaks 7 and 8 were 
identified as NFK and Trp, respectively. Of the remaining six individually purified peaks, only Peak 
6 substantially relaxed naïve arteries in a dose-dependent manner (Fig. 1d, Extended Data, fig. 1d). 
Purified Peak 6 also dose-dependently relaxed conduit and resistance arteries from mouse, rat and 
pig (Extended Data, fig. 1e-i), indicating that 1O2-mediated oxidation of Trp generates a compound 
that relaxes arteries in a vascular bed- and species-independent manner. 
To chemically identify the compound eluting in Peak 6, we analyzed ‘1O2-exposed Trp’ by 
liquid chromatography mass spectrometry (LC-MS). The compounds eluting in Peaks 5 and 6 had a 
molecular weight of 236 (single ions with mass-to-charge ratio, m/z 237), while the compounds 
eluting in Peaks 2 and 4 had a m/z of 221 (Extended Data, fig. 2a). This suggests the incorporation 
of two and one oxygen atom(s) into Trp (m/z 205), respectively. MS/MS fragmentation spectra 
(Extended Data, fig. 2b) indicated the compounds of Peaks 2 and 4, and Peaks 5 and 6 to be isomers 
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of each other. Analysis by 1H and 13C nuclear magnetic resonance (NMR) suggested that the 
molecules eluting in Peaks 5 and 6 in the HPLC are tricyclic Trp-derived hydroperoxides with O2 
incorporated at carbon 3a4, and the molecules eluting in Peaks 2 and 4 are the corresponding 
tricyclic hydroxides (trans- and cis-WOH, respectively) (Extended Data, table 1). We confirmed 
Peaks 5 and 6 as hydroperoxides by HPLC with post-column chemiluminescence detection14 
(Extended Data, fig. 2c). Their chemical reduction eliminated the chemiluminescence response 
(Extended Data, fig. 2d) and resulted in retention times, molecular ions and fragmentation patterns, 
and 1H NMR spectra identical to those of Peaks 2 and 4, respectively (Extended Data, figs. 3a-b). 
This data confirmed that Peaks 2 and 4 are the hydroxides of the corresponding hydroperoxides, 
Peaks 5 and 6, respectively. 
To unequivocally assign the stereochemistry of the molecules eluting in Peaks 5 and 6, we 
performed Nuclear Overhauser Effect (NOE)-difference NMR on the corresponding stable 
hydroxides, Peaks 2 and 4. Irradiation of the resonance at ~5.2 ppm, corresponding to proton H8a in 
the 1H NMR of purified Peaks 2 and 4, resulted in a clear NOE signal with the α-hydrogen (H2) in 
the case of Peak 2 but not Peak 4 (Extended Data, figs. 3c-f). The NOE signal is indicative of 
protons H8a and H2 being on the same face of the molecule and suggests that Peak 2 corresponds to 
the trans-configured tricyclic hydroxide. From these findings, extensive 2D NMR analyses, and 
comparison of the NMR data with relevant literature4,15, we concluded that the molecule eluting in 
Peak 6 is the tricyclic Trp-derived cis-hydroperoxide ((2S,3aR,8aR)-3a-hydroperoxy-1,2,3,3a,8,8a-
hexahydropyrrolo[2,3-b]indole-2-carboxylic acid), hereafter referred to as cis-WOOH, while the 
molecule that eluted in Peak 5 is the corresponding 3a, 8a-epimer trans-WOOH (Fig. 1a). 
Incubation of cis-WOOH at 37 °C and pH 7.4 led to its stoichiometric conversion to NFK, as 
examined by spectrophotometry, NMR and LC-MS/MS (Extended Data, figs. 4a-c), establishing 
cis-WOOH as a precursor of NFK. Thermal decomposition of cis-WOOH also led to emission of 
light with maxima at 489 nm, characteristic of activated carbonyls16 (Extended Data, fig. 4d). Based 
on these findings and known chemistry4, a plausible scheme for 1O2-mediated conversion of Trp to 
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cis-WOOH and its decay to NFK is proposed (Extended Data, fig. 4e). 
IDO1 is known to require reduction of its Fe3+-heme prosthetic group to Fe2+-heme for 
activity17. Using superoxide radical anion (O2•–) or cytochrome b5/cytochrome P450 reductase as a 
reducing system18, IDO1 converted Trp to NFK and small amounts of cis-WOH, but not cis-
WOOH (Fig. 2a, top/middle), demonstrating that cis-WOOH is not a product of reductively 
activated IDO1 activity. Because inflammation is associated with increased H2O2 and IDO1 also 
possesses peroxidase activity19, we examined Trp oxidation by IDO1 in the presence of H2O2. 
Under these conditions, cis-WOOH was formed as the major product, in addition to NFK, the 
peroxidase product oxyindolylalanine20, and trace amounts of trans-WOOH (Fig. 2a bottom, Fig. 
2b). In contrast, oxidation of Trp with chemically generated 1O2 yielded more comparable amounts 
of cis- and trans-WOOH (Extended Data, figs. 5a-b), indicating that IDO1/H2O2 formed cis-
WOOH as an enzymatic reaction product. Consecutive addition of sub-stoichiometric amounts of 
H2O2 to IDO1 resulted in H2O2 concentration-dependent increase in cis-WOOH, with ~0.3 mol cis-
WOOH formed per mol H2O2 (Fig. 2b). Pharmacological inhibitors of IDO1 decreased IDO1/H2O2-
mediated formation of cis-WOOH, with the L-isomer of 1-methyltryptophan (1-MT) being more 
effective than the D-isomer, and with epacadostat and NLG919 (IDO1 inhibitors of interest as 
potential anti-cancer adjunct therapies21) being more effective than 1-MT (Extended Data, fig. 5c). 
Mechanistic studies revealed that cis-WOOH is the product of a previously unrecognized 
oxidatively activated dioxygenase activity of IDO1: replacing 16O2 with 18O2 increased the m/z of 
cis-WOOH by 4 amu to 241, whereas cis-WOOH retained an m/z of 237 in reactions using 16O2 and 
H218O2 instead of H216O2 (Fig. 2c). This demonstrated that the two oxygen atoms inserted into Trp 
to form cis-WOOH are derived from O2 rather than H2O2. Saturating the reaction mixture with O2 
caused a small but significant increase in cis-WOOH, while displacing O2 in the reaction mixture 
with argon decreased cis-WOOH (and NFK) but not oxyindolylalanine (Extended Data, fig. 5d), 
thereby confirming the O2-dependence of the Trp to cis-WOOH conversion. 
To determine whether cis-WOOH is formed in vivo, we pretreated porcine coronary arteries 
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with interferon-γ to increase IDO1 expression6 and to mimic inflammatory conditions. Such 
treatment increased arterial H2O2 (Fig. 2d) and led to formation of cis-WOOH detected as arterial 
conversion of 15N2 Trp to 15N2 cis-WOOH (Fig. 2e). Furthermore, addition of catalase conjugated to 
polyethylene glycol to scavenge arterial H2O2 (but not polyethylene glycol alone) attenuated Trp-
induced relaxation of interferon-γ-pretreated mouse arteries (Extended Data, fig. 5e). These data 
suggest that under inflammatory conditions arteries produce cis-WOOH from Trp. 
We next examined whether IDO1 in the presence of H2O2 generates 1O2. Addition of H2O2 to 
Singlet Oxygen Sensor Green (SOSG) and IDO1 resulted in an immediate increase in fluorescence 
characteristic of the 1O2-specific SOSG endoperoxide that was absent in the presence of Trp or 
when IDO1 was replaced with albumin (Extended Data, fig. 5f). Similarly, IDO1/H2O2 converted 
anthracene-9,10-diyldiethane-2,1-diyl disulfate disodium salt (EAS)16 to its 1O2-specific 
endoperoxide, EAS-O2 (Extended Data, fig. 5g). Unambiguous evidence for the formation of 1O2 by 
IDO1/H2O2 was obtained using near infrared emission at 1270 nm, which corresponds to the singlet 
delta state monomolecular light emission decay of 1O222. Addition of active, but not heat-inactivated 
IDO1, to H2O2 concentration-dependently increased 1270 nm emission (Fig. 3a). Performing the 
reaction in H2O rather than D2O, removing oxygen, or adding carbon monoxide prevented 1O2 
generation (Fig. 3a, Extended Data, figs. 5h-i), indicating the requirement of the heme iron of IDO1 
for 1O2 formation. Nitric oxide partially inhibited 1O2 formation (Fig. 3a, Extended Data, fig. 5h), 
consistent with its known reversible inhibition of IDO1 activity23. Performing the reaction in D2O 
(to extend the half-life of 1O222) increased the yield of cis-WOOH relative to that of 
oxyindolylalanine (Fig. 3b), while the structurally diverse 1O2 scavengers L-histidine, SOSG, cis-
norbixin and urate decreased the cis-WOOH yield (Fig. 3c). Moreover, LC/MS-based quantification 
of IDO1/H2O2-mediated conversion of EAS to EAS endoperoxide revealed comparable amounts of 
1O2 and cis-WOOH were formed (Fig. 3d), indicating that the 1O2 generated by IDO1/H2O2 
accounted for most cis-WOOH formed. Similarly, the amounts of cis-WOOH formed by 
IDO1/H2O2 were comparable to the extent of conversion of urate to its 1O2-specific oxidation 
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product, parabanic acid24 (Fig. 3e), confirming that urate inhibited IDO1/H2O2-mediated cis-
WOOH formation by scavenging of 1O2. Together, these results suggest that IDO1/H2O2 generate 
cis-WOOH from Trp via 1O2, and that 1O2 is formed in or near the active site of the enzyme rather 
than being released into the bulk phase. 
If 1O2 were required for conversion of Trp to cis-WOOH, other enzymes known to form 1O2 in 
the presence of H2O225 may also be able to convert Trp to cis-WOOH. Indeed, horseradish 
peroxidase and myeloperoxidase, as well as purified IDO2, formed cis-WOOH, albeit with lower 
stereospecificity than IDO1 (Extended Data, fig. 5j). The fact that IDO2 generated cis-WOOH in 
the presence of H2O2 raised the possibility that IDO2 may also contribute to Trp-mediated arterial 
relaxation under inflammatory conditions. However, Trp-induced relaxation of IFNγ-pretreated 
abdominal aortas of Ido1–/– and Ido1–/–Ido2–/– mice was comparable (Extended Data, fig. 5k), 
indicating that under the conditions tested IDO2 may not significantly contribute to arterial 
relaxation, consistent with a lack of evidence for arterial expression of IDO2 in naïve animals or 
under conditions of inflammation. Experiments probing the mechanism of 1O2 generation by 
IDO1/H2O2 indicated the involvement of protein peroxy radicals (Extended Data, fig. 6) and the 
Russell mechanism26 as a possible pathway (Extended Data, figure 1a). 
To examine the role of 1O2 in Trp-induced IDO1-mediated arterial relaxation, we added the 1O2 
scavengers L-histidine, urate or cis-norbixin to interferon-γ-pretreated arteries. This attenuated 
relaxation mediated by Trp but not nitric oxide (Fig. 3f-g, Extended Data, fig. 5l), an effect seen 
with arteries from wildtype but not Ido1–/– mice (Fig. 3f). Moreover, addition of urate to interferon-
γ-pretreated arteries resulted in the accumulation of parabanic acid (Fig. 3h), indicating that IDO1-
expressing arteries form 1O2 under conditions that mimic inflammation. 
We next focused on the mechanism of cis-WOOH-mediated relaxation of resistance arteries. 
The cGMP-competitive protein kinase G (PKG) inhibitor RP-8CPT modestly attenuated relaxation, 
whereas the ATP-competitive PKG inhibitor KT5823 was more effective (Extended Data, figs. 7a-
b), suggesting cGMP-independent activation of PKG by cis-WOOH. PKG1α is known to undergo 
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H2O2-mediated oxidative dimerization through cysteine residue 42 (C42), which is associated with 
enzyme activation27. Intriguingly, cis-WOOH, but not trans-WOOH, dimerized purified 
recombinant human PKG1α, independent of the presence of transition metals and light, but 
dependent on C42 of PKG1α (Fig. 4a). Exposure of resistance arteries of wildtype (Fig. 4b, left) 
and Ido1–/– mice (Fig. 4b, right) to cis-WOOH also caused PKG1α dimerization, as was observed 
with Trp addition to IDO1-expressing arteries (Fig. 4c). Compared with the wildtype counterparts, 
mesenteric arteries from PKG1α C42S knock-in mice28 showed blunted relaxation in response to 
cis-WOOH and Trp (Fig. 4d), but not the nitric oxide donor DEANO (Extended Data, fig. 7c). 
As Ido1–/– mice are partially protected from hypotension induced by experimental cerebral 
malaria and endotoxemia6, we compared systolic blood pressure responses in unconscious 
endotoxemic wildtype and PKG1α C42S knock-in mice. Infusion of Trp decreased blood pressure 
temporarily in wildtype but not knock-in mice (Fig. 4e), while IDO activity was comparable 
between the two genotypes (Extended Data, figs. 7d-e). In contrast to Trp, the hypotensive response 
to sodium nitroprusside, that activates PKG1α via the canonical non-oxidative pathway, was 
comparable in wildtype and PKG1α C42S knock-in mice (Fig. 4f). These data suggest that the Trp-
induced decrease in blood pressure of endotoxemic mice is mediated via non-canonical oxidative 
activation of PKG1α involving C42. 
As H2O2 itself can induce arterial relaxation via C42-dependent oxidative dimerization of 
PKG1α, we asked whether this pathway overlaps with PKG1α oxidation by cis-WOOH by testing 
the effect of Trp on acetylcholine-induced relaxation of resistant mesenteric arteries that is mediated 
by H2O2.29 Trp and 1-MT had no material effect on arteries isolated from naïve mice (Fig. 4g), 
whereas Trp sensitized and 1-MT attenuated relaxation of arteries from endotoxemic mice (Fig. 4h). 
Moreover, addition of Trp to IDO1-expressing human vascular smooth muscle cells enhanced 
PKG1α dimerization by H2O2 concentrations that alone did not induce measurable dimerization 
(Extended Data, fig. 7f). These findings suggest that under inflammatory conditions, H2O2-induced 
arterial relaxation via PKG1α oxidation may be partially mediated by IDO1/cis-WOOH. 
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We finally tested a potential role of IDO1/cis-WOOH in cardiac pathophysiology related to 
pressure-overload, where PKG1α oxidation has been implicated30. We found no evidence for IDO1 
expression and hence role in cardiac tissue after pressure-overload (Extended Data, fig. 8a). In 
contrast, IDO1 was expressed in conduit arteries with underlying atherosclerosis and in resistance 
arteries of apolipoprotein E gene knockout (Apoe–/–) but not Apoe–/–Ido1–/– mice (Extended Data, 
figs. 8b-c). Moreover, IDO1 contributed to the regulation of blood pressure in Apoe–/– but not in 
Apoe–/–Ido1–/– mice (Extended Data, figs. 8d-e), indicating that the pathway identified here may 
play a role in blood pressure regulation in atherosclerosis, an inflammatory disease. 
In summary, we have demonstrated that 1O2 plays an important pathophysiological role in the 
redox regulation of arterial relaxation and blood pressure in mammals under inflammatory 
conditions where IDO1 is expressed. While mammalian enzymes such as myeloperoxidase have 
long been known to form 1O225, a physiological or pathophysiological role for 1O2 in mammals 
outside photosensitization reactions has not been established to date. Our findings also suggest an 
expanded range of biological functions for IDO1, and serve as the starting point for discovery of a 
refined repertoire of redox signaling paths by H2O2. For example, the biological activities 
uncovered here highlight the IDO1/PKG1α axis as a possible therapeutic target in sepsis, where 
oxidative activation of PKG1α31 and IDO1 activity are prevalent32. They also raise the possibility 
that the reactive and potentially cytotoxic 1O233 may contribute to IDO1-mediated immune 
tolerance and tumor evasion, with inhibition of IDO1 representing a major target of anti-cancer 
drug development34,35. Our study shifts focus from H2O2 to an amino acid-derived hydroperoxide as 
a stereospecific signaling molecule. Other heme proteins known to generate 1O2 in the presence of 
H2O225 may therefore also play key roles in redox signaling by forming products that, like cis-
WOOH, act as signaling molecules. 
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Figure Legends 
Figure 1. Identification of a tryptophan-derived tricyclic hydroperoxide as an arterial 
relaxant. a, Schematic of oxidation of L-tryptophan (Trp) by IDO1 (left) and 1O2 (right). b, d, 
Relaxation of pre-constricted endothelium-denuded naïve abdominal aortas to increasing amounts 
of 1O2-exposed Trp containing all compounds present in the crude reaction mixture (b) and HPLC-
purified Peak 6 (d). c, Typical HPLC chromatogram of the crude reaction mixture obtained after 
1O2 oxidation of Trp for 9 h (n=6), with numbers in bracket referring to the mass-to-charge ratio 
(m/z) of the compounds eluting as peaks 2, 4, 5 and 6. Data in b and d are mean ± s.e.m. of n=4 and 
6 independent experiments, respectively. *p<0.001 compared with vehicle using Kruskal-Wallis 
with Dunn’s post hoc test. AU, arbitrary units; NE, norepinephrine. 
Figure 2. Arterial formation of cis-WOOH via oxidative activation of IDO1 dioxygenase 
activity. a, Total LC-MS/MS ion chromatogram of reaction mixtures of recombinant IDO1 and Trp 
under reducing (top, superoxide; middle, cytochrome b5) and oxidizing conditions (bottom, H2O2). 
b, IDO1-mediated formation of Trp-derived metabolites with successive addition of H2O2. The 
chemical structure of the peroxidase product, oxyindolylalanine (OIA), is shown. c, Full mass 
spectra of cis-WOOH derived from the reaction of IDO1 and H2O2 with Trp in 16O2 (top, bottom) or 
18O2 air (middle), with H2O2 being replaced with H218O2 (bottom). d, Endogenous formation of 
H2O2 by porcine arteries in the absence (–) and presence of 400 ng mL-1 recombinant porcine 
interferon-γ (rpIFNγ) (+). e, Endogenous formation of 15N2 cis-WOOH from 15N2 L-Trp by porcine 
arteries pretreated with 0, 200 or 400 ng mL-1 rpIFNγ. Data are representative of 3 independent 
experiments (a, c) or mean ± s.e.m. of 3 (b, e) and 5 (d) independent experiments. p-values 
determined by Mann-Whitney rank sum test (one-sided) (d) or Kruskal-Wallis with Dunn’s post-
test (e). cis-WOH, hydroxide of cis-WOOH; m/z, mass-to-charge ratio. 
Figure 3. Generation of 1O2 by IDO1 and H2O2 is required for formation of cis-WOOH and 
arterial relaxation. a, Near infrared (NIR) emission upon addition of enzymatically active (black) 
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or heat-inactivated (grey) IDO1 to H2O2 before and after Trp addition (left). Difference in NIR 
emission induced under different experimental conditions (right): b, IDO1/H2O2-mediated 
conversion of Trp to cis-WOOH in phosphate buffer containing H2O or D2O with data expressed as 
a ratio of cis-WOOH/oxyindolylalanine (OIA). c, Formation of cis-WOOH by IDO1/H2O2 ± L-
histidine (L-His), Singlet Oxygen Sensor Green (SOSG), cis-norbixin and urate, with data 
expressed as yield relative to that in the absence of 1O2 scavenger (control). d, Estimation of the 1O2 
generated by IDO1/H2O2 by quantifying the conversion of anthracene-9,10-diyldiethane-2,1-diyl 
disulfate disodium salt (EAS) to its endoperoxide, EAS-O2. e, Quantification of IDO1/H2O2-
mediated conversion of Trp to cis-WOOH, and urate to parabanic acid, in the absence (–) and 
presence of urate (+). f, g Relaxation of mouse abdominal aortas pretreated with interferon-γ ± L-
His (f), urate (g) or vehicle in response to Trp or sodium nitroprusside (SNP). h, Formation of 
parabanic acid by porcine coronary arteries pretreated with 0 or 400 ng mL-1 recombinant porcine 
interferon-γ (rpIFNγ) for 51 h and 8 h in MOPS buffer prior to addition of urate. Data are 
representative of 3 (a left) independent experiments or mean ± s.e.m. of 3 (a right, c-f, h) or 4 (b) 
independent experiments, while data in g are mean ± s.e.m. of n=7 (Trp) and n=4 (SNP) 
experiments. p-values determined by one-tailed Mann-Whitney compared with standard reaction 
condition using 1 µM IDO1 (a, c) or as indicated (b, f-h). DHPNO2, endoperoxide of N,N-di(2,3-
dihydroxypropyl)-1,4-naphthalene dipropanamide, used as a positive control; 1, 1 µM IDO1; 2, 2 
µM IDO1; N2, reaction mixture bubbled with N2 to remove O2; CO and NO, IDO1 treated with CO 
and NO, respectively. 
Figure 4. Regulation of arterial relaxation and blood pressure by IDO1-mediated Trp 
metabolism is dependent on cysteine residue 42 of PKG1α . a, Dimerization of recombinant 
human wildtype and cysteine 42 serine (C42S) mutant PKG1α by cis- and trans-WOOH ± light and 
the transition metal chelator diethylenetriaminepentaacetic acid (DTPA); n=3 separate experiments. 
b, c, Dimerization of PKG1α in mouse mesenteric resistance arteries by (b) cis-WOOH (left, naïve 
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arteries from wildtype mice, n=5), (right, naïve arteries from Ido1–/– mice, n=4) or (c) Trp (arteries 
from lipopolysaccharide (LPS)-treated wildtype animals, n=4). d, Relaxation of pre-constricted 
mouse mesenteric resistance arteries from wildtype (black) and PKG1α C42S knock-in mice (grey) 
by cis-WOOH (naïve arteries, n=3 for both genotypes), or Trp (n=4 for both genotypes). e, f, Blood 
pressure responses elicited by Trp (e), sodium nitroprusside (SNP) (f) in endotoxemic wildtype 
(black, n=8 for Trp, n=4 for SNP) or PKG1α C42S knock-in mice (grey, n=9 for Trp and SNP). g, 
h, Acetylcholine (ACh)-induced relaxation of mouse mesenteric resistance arteries from naïve (g) 
or LPS-treated (h) wildtype mice in the absence (control, n=4 for naïve, n=13 for LPS) or presence 
of Trp (n=4 for naïve, n=10 for LPS) or 1-L-methyltryptophan (1-MT, n=4 for naïve, n=8 for LPS). 
Data are representative or mean ± s.e.m. *#p≤0.05 as determined by Mann-Whitney rank sum test 
(a-c), 2-way ANOVA with Šidák post-hoc test (d), Kruskal Wallis with Dunn’s test (e, f), and one-
way ANOVA of maximal relaxation values with Dunnett’s test (g, h). 
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Methods 
Reagents. Reagents were supplied from Sigma-Aldrich except for Annatto (Lab Seeker Inc.), 
NLG919 (Advanced ChemBlocks Inc.), Singlet Oxygen Sensor Green (Molecular Probes), DEANO 
and U46619 (Cayman Chemicals), protease inhibitors (Roche), H218O2 (90% 18O2,	 ICON isotopes, 
IO 6325sp), 15N2 tryptophan (CNLM-6077; Cambridge Isotope Laboratories), all species of 
recombinant interferon γ (R&D Systems), and human myeloperoxidase (Planta). Recombinant 
human IDO2 (N-terminal truncated version of the predicted protein sequence consisting of residues 
14–420, cloned and purified as described previously36) was generously provided by Dr. Hajime 
Yuasa (National University Corporation Kochi University, Kochi, Japan). Cell culture reagents and 
molecular biology reagents were purchased from Invitrogen unless indicated otherwise. 
Bicinchoninic acid assay (BCA) reagent was purchased from Thermo Fisher. Solvents were of 
analytical grade and purchased from Thermo Fisher, except for NMR studies which used solvents 
obtained from Cambridge Isotope Laboratories.  
Preparation and purification of chemicals. Semi-preparative HPLC was used to purify 
commercial L-tryptophan (Trp) (Sigma-Aldrich T0254), L-kynurenine (Kyn, K8625) and 1-L-
methyltryptophan (1-L-MT, Sigma-Aldrich 447439). N-Formylkynurenine (NFK) was prepared by 
treating L-kynurenine with acetic anhydride in formic acid, followed by extraction with diethyl 
ether and drying of the resulting precipitate under vacuum. The purity of NFK was verified by LC-
MS. cis-WOOH and trans-WOOH, prepared by 1O2-mediated oxidation of Trp as described below, 
were purified by semi-preparative HPLC, their purity verified by Nuclear Magnetic Resonance 
(NMR) spectroscopy and liquid chromatography tandem mass spectrometry (LC-MS/MS), and then 
frozen immediately and stored at -80 °C under an atmosphere of argon and in the presence of a 
desiccant. For transport between laboratories, cis- and trans-WOOH were kept on dry ice or under 
liquid nitrogen vapor. On the day of experimentation, cis- and trans-WOOH were brought to room 
temperature, weighed and working solutions prepared immediately prior to use. 
cis-Norbixin was purified from Annatto extracts as described previously37. Briefly, Annatto 
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extract (50.0 g) was dissolved in 250 mL of aqueous NaOH (4% w/v) and stirred at 37 °C for 14 h. 
The solution was then cooled to 0 °C and acidified with HCl to pH = 2 before being extracted with 
ethyl acetate (4 x 300 mL). This yielded approximately 5.5 g of crude organic soluble material. This 
crude material was then purified in batches. 50 mg was dissolved in 1 mL DMSO and purified by 
reversed phase HPLC using a Waters 600 Multisolvent Delivery System Waters equipped with a 
Waters 500 pump, a 2996 photodiode array detector set at 214 and 350 nm, and an XBridge Prep 
C8 5 µm OBD 30 x 150 mm column eluted at a flow rate of 40 mL min-1 over 25 min using a linear 
gradient of 40-100 vol.% acetonitrile (0.1% trifluoroacetic acid, TFA) in H2O (0.1% TFA). Eluting 
fractions were analyzed for cis-norbixin (m/z 381 [M+H]+) by low-resolution mass spectrometry 
using a Shimadzu 2020 (electrospray ionization, ESI) LC-MS operating in positive ion mode. 
Fractions containing pure product from four HPLC runs were combined and lyophilized to yield 
cis-norbixin as a red fluffy solid (17 mg, 8.5% recovery from 200 mg crude material). The identity 
and purity of cis-norbixin (>95%) was confirmed by NMR spectroscopy using a Bruker DRX 500 
instrument operating at 500 MHz for 1H and 125 MHz for 13C and referenced to the residual DMSO 
signal. 1H-NMR (DMSO-d6, 500 MHz) δ (ppm) 7.81 (d, J = 15.5 Hz, 1H), 7.26 (d, J = 15.4 Hz, 
1H), 6.85 (dd, J = 14.9, 11.8 Hz, 1H), 6.81-6.78 (m, 2H), 6.70 (dd, J = 14.6, 11.5 Hz, 1H), 6.62 (d, 
J = 11.2 Hz, 1H), 6.60 (d, J = 14.9 Hz, 1H), 6.51 (d, J = 14.9 Hz, 1H), 6.48-6.41 (m, 3H), 5.87 (d, J 
= 15.5 Hz, 1H), 5.83 (d, J = 15.5 Hz, 1H), 1.98 (s, 3H), 1.97 (s, 3H), 1.93 (s, 3H), 1.92 (s, 3H); 13C-
NMR (DMSO-d6, 125 MHz) δ (ppm) 167.9, 167.9, 148.0, 141.4, 140.1, 139.0, 138.9, 137.1, 136.7, 
136.6, 134.7, 134.3, 133.4, 131.5, 131.4, 131.2, 124.8, 123.2, 119.7, 117.5, 20.0, 12.7, 12.6, 12.5. 
Synthesis of Epacadostat. Epacadostat was synthesized according to the reported procedure38 with 
slight modifications (Extended Data, figure 9b). 
Experimental reagents—All non-aqueous reactions were performed under an atmosphere of dry 
nitrogen, unless otherwise specified. Solvents were of analytical grade: tetrahydrofuran (THF); 
ethyl acetate (EtOAc); dichloromethane (DCM); acetonitrile (MeCN); petroleum benzine (PB); 
ethanol (EtOH); and methanol (MeOH). Thin-layer chromatography (TLC) was performed on silica 
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gel 60F254 pre-coated aluminum sheets (0.25 mm, Merck). Flash column chromatography was 
carried out using Merck silica gel 60, 0.63 – 0.20 mm (70-230 mesh). Automated flash column 
chromatography was performed with a Biotage Isolera One instrument using Biotage SNAP 
cartridges packed with silica (KP-SilTM). 
NMR analyses—1H- and 13C-NMR spectra were recorded on a Bruker Avance III Nanobay 400 
MHz spectrometer coupled to the BACS 60 automatic sample changer. Results are recorded as 
follows: chemical shifts (δ) in ppm acquired in either CDCl3 (7.26 ppm for 1H) or DMSO-d6 (2.50 
ppm for 1H) as a reference. Each proton resonance was assigned according to the following 
convention: chemical shift (δ), multiplicity, coupling constant (J Hz) and number of protons. In 
reporting of the spectral data, the following abbreviations are utilized: s, singlet; d, doublet; t, 
triplet; q, quartet; m, multiplet. 
Low-resolution mass spectrometry analyses—An Agilent 1290 Infinity combined with an Agilent 
6224 TOF LC/MS Mass Spectrometer (Agilent Technologies Inc) was used. All data were acquired 
and reference mass corrected via a dual-spray ESI source. Each scan or data point on the Total Ion 
Chromatogram (TIC) is an average of 13,700 transients, producing a spectrum every second. Mass 
spectra were created by averaging the scans across each peak and background subtracted against the 
first 10 s of the TIC. Acquisition was performed using the Agilent Mass Hunter Data Acquisition 
software version B.05.00 Build 5.0.5042.2, and analysis was performed using Mass Hunter 
Qualitative Analysis version B.05.00 Build 5.0.519.13. Chromatographic separation was performed 
using a Zorbax SB-C18 Rapid Resolution HT 2.1 x 50 mm, 1.8 µm column (Agilent Technologies 
Inc) using an acetonitrile gradient (5% to 100%) over 3.5 min at 0.5 mL min-1. 
High-resolution mass spectrometry—An Agilent 1290 Infinity combined with an Agilent 6224 
TOF LC/MS Mass Spectrometer (Agilent Technologies Inc) was used. All data were acquired and 
reference mass corrected via a dual-spray ESI source. Each scan or data point on the TIC is an 
average of 13,700 transients, producing a spectrum every second. Mass spectra were created by 
averaging the scans across each peak and subtracting the background from the first 10 s of the TIC. 
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Acquisition was performed using the Agilent Mass Hunter Data Acquisition software version 
B.05.00 Build 5.0.5042.2 and analysis was performed using Mass Hunter Qualitative Analysis 
version B.05.00 Build 5.0.519.13. Acquisition parameters: mode, ESI; drying gas flow, 11 L/min; 
nebulizer pressure, 45 PSI; drying gas temperature, 325 °C; voltages: capillary, 4,000 V; 
fragmentor, 160 V; skimmer, 65 V; octapole RF, 750 V; scan range, 100–1,500 m/z; positive ion 
mode internal reference ions, m/z 121.050873 and 922.009798. LC conditions: Agilent Zorbax SB-
C18 Rapid Resolution HT (2.1 × 50 mm, 1.8 µm column), 30 °C; sample 13 (5 µL) was eluted 
using a binary gradient (solvent A: 0.1% aq. HCO2H; solvent B: 0.1% HCO2H in CH3CN; 5–100% 
B [3.5 min], 0.5 mL min-1). 
Analytical high-performance liquid chromatography—Analytical HPLC was acquired on an 
Agilent 1260 Infinity analytical HPLC coupled with a G1322A degasser, G1312B binary pump, 
G1367E high-performance autosampler, and G4212B diode array detector. Conditions were as 
follows: Zorbax Eclipse Plus C18 rapid resolution column (4.6 × 100 mm) with UV detection at 
254 and 214 nm, 30 °C; the sample was eluted using a gradient of 5-100% solvent B in solvent A, 
where solvent A was 0.1% aq. TFA and solvent B was 0.1% TFA in CH3CN (5−100% B [9 min], 
100% B [1min]; 0.5 mL min-1). 
4-Amino-N'-hydroxy-1,2,5-oxadiazole-3-carboximidamide 2—Malononitrile 1 (6.0 g, 90.8 mmol) 
was added to preheated H2O (150 mL, 45 °C) and stirred for 5 min. The resulting solution was 
cooled in an ice/water bath, and sodium nitrite (6.9 g, 99.9 mmol) was added and the solution 
stirred for a further 5 min. Then, HCl (10 M, 6.2 mL) was added slowly. After 3 min, the ice/water 
bath was removed, and the reaction mixture was stirred for 1.5 h at room temperature. 
Hydroxylamine (9.0 g, 273.5 mmol) was added and the reaction mixture stirred for 1 h, before 
refluxing for another 2 h and cooling in an ice/water bath. The resulting solution was neutralized to 
pH 7. The precipitate was collected by filtration, washed well with H2O, and dried in a vacuum to 
give the title compound as a brown solid (11.3 g, 90%). 1H NMR (400 MHz, DMSO) δ 10.45 (s, 
1H), 6.26 (s, 2H), 6.17 (s, 2H). 13C NMR (101 MHz, DMSO) δ 154.4, 143.9, 140.0. LC-MS Rt 0.70 
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min, m/z 144 [M + H]+. HRMS-ESI m/z [M + H]+ for C3H5N5O2+ calculated	 144.0516, found 
144.0521. 
4-Amino-N-hydroxy-1,2,5-oxadiazole-3-carbimidoyl chloride 3—Compound 2 (2.0 g, 13.98 mmol) 
and NaCl (2.45 g, 41.93 mmol) were added to a mixture of H2O (27 mL), acetic acid (15 mL), and 
HCl (10 M, 7 mL). The suspension was stirred at room temperature until complete solution was 
achieved and then cooled in an ice/water bath. A solution of sodium nitrite (0.94 g, 13.7 mmol) in 
water (3.0 mL) was added, and stirred at room temperature overnight. The precipitate was collected 
by filtration, washed well with H2O, taken into EtOAc and dried over MgSO4. The suspension was 
filtered, and the filtrate evaporated to give the title compound as a pale brown solid (1.1 g, 56%). 1H 
NMR (400 MHz, DMSO) δ 13.37 (s, 1H), 6.28 (s, 2H). 13C NMR (101 MHz, DMSO) δ 154.0, 
141.9, 126.5. LC-MS Rt 0.77 min, m/z 187 [M + Na]+. HRMS-ESI m/z [M + H]+ for C3H3ClN4O2+ 
calculated	163.0017, found 163.0020. 
4-Amino-N-(3-bromo-4-fluorophenyl)-N'-hydroxy-1,2,5-oxadiazole-3-carboximidamide 5—
Compounds 3 (1.0 g, 6.15 mmol) and 4 (1.29 g, 6.77 mmol) were dissolved in EtOH (30 mL), 
before addition of NaHCO3 (1.3 g, 15.4 mmol) in H2O (10 mL). The reaction was stirred and heated 
at 60 °C for 1 h. The solvent was removed, and the resulting residue was taken up into EtOAc and 
washed with brine. The organic layer was dried over MgSO4, filtered and concentrated. The crude 
product was purified by flash chromatography, eluting with 20-60% EtOAc/petroleum benzine to 
give the tile compound as a brown solid (1.7 g, 89%). 1H NMR (400 MHz, DMSO) δ 11.42 (s, 1H), 
8.86 (s, 1H), 7.18 (t, J = 8.8 Hz, 1H), 7.10 (dd, J = 6.1, 2.7 Hz, 1H), 6.77 (ddd, J = 8.9, 4.2, 2.8 Hz, 
1H), 6.25 (s, 2H). LC-MS Rt 3.41 min, m/z 317 [M + H]+. HRMS-ESI m/z [M + H]+ for 
C9H7BrFN5O2+ calculated	317.9829, found 317.9820. 
3-(4-Amino-1,2,5-oxadiazol-3-yl)-4-(3-bromo-4-fluorophenyl)-1,2,4-oxadiazol-5(4H)-one 6—
Carbonyldiimidazole (0.342 g, 4.75 mmol) was added to a stirring solution of 5 (1.0 g, 3.16 mmol) 
in THF (50 mL). The reaction solution was heated to reflux for 3 h (monitored by TLC and LCMS). 
The solvent was removed, and the resulting residue was taken up into EtOAc (100 mL) and washed 
	 26 
with 1 M HCl (2 x 50 mL). The organic layer was dried over MgSO4, filtered and concentrated. The 
crude product was purified by flash chromatography, eluting with 0-60% EtOAc/petroleum benzine 
to give the title compound as an off-white solid (0.59 g, 55%). 1H NMR (400 MHz, DMSO) δ 8.15 
(dd, J = 6.2, 2.5 Hz, 1H), 7.78 (ddd, J = 8.8, 4.4, 2.5 Hz, 1H), 7.66 (t, J = 8.7 Hz, 1H), 6.66 (s, 2H).	
13C NMR (101 MHz, DMSO) δ 160.3, 157.8, 155.2, 148.9, 134.2, 133.4, 130 (JCF = 8.4 Hz), 128.7, 
117.5 (JCF = 24.2 Hz), 108.2 (JCF = 22.9 Hz). 19F NMR (376 MHz, DMSO) δ -105.54. LC-MS Rt 
3.47 min, m/z 341.8 [M – H]–. HRMS-ESI m/z [M - H]– for C10H5BrFN5O3S- calculated	339.9487, 
found 339.9476. 
Benzyl N-(2-((4-(4-(3-bromo-4-fluorophenyl)-5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-1,2,5-
oxadiazol-3-yl)amino)ethyl)sulfamoylcarbamate  —A solution of 6 (0.5 g, 1.47 mmol) and 7 (1.4 g, 
4.41 mmol) in dichloromethane was added to trifluoroacetic acid (2.24 mL, 29.2 mmol) and 
triethylsilane (0.77 mL, 4.82 mmol) dropwise at 0 °C. The reaction mixture was stirred at the same 
temperature for 2 h (monitored by LC-MS). The reaction mixture was quenched with saturated 
NaHCO3 to pH 8 and extracted with EtOAc (3 x 30 mL). The combined organic layers were 
washed with brine, dried over MgSO4, filtered and concentrated. The crude product was purified by 
flash chromatography, eluting with 0-50 EtOAc/petroleum benzine to give the title compound as a 
colorless solid (0.68 g, 78%). 1H NMR (400 MHz, DMSO) δ 11.34 (s, 1H), 8.10 (dd, J = 6.2, 2.5 
Hz, 1H), 7.93 (s, 1H), 7.74 (ddd, J = 8.8, 4.4, 2.5 Hz, 1H), 7.60 (t, J = 8.7 Hz, 1H), 7.46 – 7.28 (m, 
5H), 6.58 (t, J = 5.9 Hz, 1H), 5.12 (s, 2H), 3.38 (dt, J = 10.5, 5.3 Hz, 2H), 3.15 (dd, J = 12.3, 6.3 
Hz, 2H). 19F NMR (376 MHz, DMSO) δ -105.43. LC-MS Rt 3.61 min, m/z 595.7 (79Br), 597.7 
(81Br) [M - H]–. HRMS-ESI m/z [M + H]+ for C20H17BrFN7O7S+ calculated	 598.0150, found 
598.0164. 
N-[2-({4-[4-(3-Bromo-4-fluorophenyl)-5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl]-1,2,5-oxadiazol-3-
yl}amino)ethyl]sulfamide 9— A mixture of 8 and HBr (33 wt. % in acetic acid) (2 mL) was stirred 
at 0 °C for 1-2 h (monitored by TLC and LCMS). Acetic acid was removed, and EtOAc and H2O 
were added to the resulting residue and then neutralized. The organic phase was separated, and the 
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aqueous phase was further extracted with EtOAc (2x). The combined organic layers were dried over 
MgSO4 filtered and concentrated. The crude product was purified by flash chromatography, eluting 
with 10-80% EtOAc/petroleum benzine to give the title compound as a colorless solid (0.26 g, 
85%). 1H NMR (400 MHz, DMSO) δ 8.10 (dd, J = 6.2, 2.5 Hz, 1H), 7.73 (ddd, J = 8.8, 4.4, 2.5 Hz, 
1H), 7.61 (t, J = 8.7 Hz, 1H), 6.67 (t, J = 5.9 Hz, 1H), 6.58 (s, 2H), 6.53 (t, J = 5.9 Hz, 1H), 3.48 – 
3.38 (m, 2H), 3.13 (q, J = 6.3 Hz, 2H). 19F NMR (376 MHz, DMSO) δ -105.44. LC-MS Rt 3.50 
min, m/z 461.8 (79Br), 463.7 (81Br) [M + H]+. HRMS-ESI m/z [M + H]+ for C12H11BrFN7O5S+ 
calculated	463.9783, found 463.9801. 
N-(3-Bromo-4-fluorophenyl)-N'-hydroxy-4-((2-(sulfamoylamino)ethyl)amino)-1,2,5-oxadiazole-3-
carboximidamide (Epacadostat 10)—To a solution of 9 (0.17 g, 0.366 mmol) in THF (5 mL) was 
added NaOH (0.044 g, 1.10 mmol). The mixture was stirred at room temperature for 3 h, before the 
reaction mixture was acidified to pH 3-4 with 1 M HCl and extracted with EtOAc (3 x 15 mL). The 
combined organic layers were washed with H2O, brine, dried over MgSO4, filtered and 
concentrated. The crude product was purified by flash chromatography, eluting with 0-50% 
EtOAc/DCM to give the title compound as a colorless solid (0.13 g, 80%). 1H NMR (400 MHz, 
DMSO) δ 11.50 (s, 1H), 8.89 (s, 1H), 7.19 (t, J = 8.8 Hz, 1H), 7.12 (dd, J = 6.0, 2.7 Hz, 1H), 6.82 – 
6.74 (m, 1H), 6.70 (t, J = 6.0 Hz, 1H), 6.59 (s, 2H), 6.23 (t, J = 6.0 Hz, 1H), 3.41 – 3.29 (m, 2H), 
3.12 (q, J = 6.1 Hz, 2H). 13C NMR (101 MHz, DMSO) δ 156.1, 154.2 (JCF = 237.4 Hz), 140.4, 
139.8, 138.5, 125.3, 122.0, (JCF = 7.1 Hz), 116.4 (JCF = 23.2 Hz), 107.5 (JCF = 22.2 Hz),  44.1, 41.4. 
19F NMR (376 MHz, DMSO) δ -117.91. LCMS Rt 3.44 min, m/z 437.7 (79Br), 439.7 (81Br) [M + 
H]+. HRMS-ESI m/z [M + H]+ for C11H14BrFN7O4S+ calculated	437.9990, found 439.9994. HPLC 
purity >95%, Rt = 5.46 min. 
Dye sensitized singlet oxygen oxidation of L-tryptophan. L-Tryptophan (Trp, 500 mg, 2.45 
mmol) was dissolved in H2O:ethanol (95:5, 150 mL) in a 500 mL round bottom flask by heating the 
mixture. After cooling to room temperature, Rose Bengal (4,5,6,7-tetrachloro-2',4',5',7'-
tetraiodofluorescein) (7 mg, 0.07 mmol) was added, the reaction mixture cooled to 0 °C and 
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irradiated at this temperature for 9 h using a 500 W halogen lamp (Nelson, Model No. 
MWLT033C) placed at 25 cm from the reaction flask. The reaction mixture was then acidified with 
acetic acid (99.7%, 1.5 mL), warmed to room temperature, extracted with dichloromethane (2 x 100 
mL) to remove Rose Bengal, and the aqueous layer collected and lyophilized. The resulting light 
brown powder was re-dissolved in H2O and subjected to semi-preparative reversed-phase HPLC (5 
µm Waters Sunfire C18 column, 10 x 250 mm) to separate the various oxidation products (Peaks) 
by gradient elution using mobile phase A (0.1 % acetic acid in H2O) and mobile phase B (0.1% 
acetic acid in acetonitrile) at 6 mL min−1. The gradient consisted of 0-15% mobile phase B from 0-
30 min, 15-100% mobile phase B from 30-35 min before returning to 0% B by 40 min. The eluent 
was monitored at 230 nm in a UV detector and the Peaks collected, immediately flash frozen in 
liquid N2, lyophilized and stored at -80 °C before being characterized. 
Enzymatic oxidation of Trp. Recombinant human IDO1 (rhIDO1) encoded by the pQE9-IDO1 
plasmid vector was expressed in Escherichia coli as a fusion protein to a hexahistidyl tag and 
purified as described previously39,40, except that for some preparations, hemin was added instead of 
5-aminolevulenic acid as described earlier41. Different batches of purified rhIDO1 used for the 
various experiments appeared as a single major protein band at ~42 kDa on reducing SDS-PAGE 
and Coomassie Blue staining and exhibited 405 to 280 nm absorption ratios of >1.4. The 
concentration of rhIDO1 was determined spectrophotometrically (Cary 100 spectrophotometer) 
using ε405 = 159 mM-1cm-1 for Fe3+-IDO1. Recombinant human Fe3+-IDO1 protein (2 µM; unless 
otherwise stated) and Trp (100 µM) were incubated at 25 °C for 15 min in the presence of 
diethylenetriaminepentaacetic acid (DTPA, 100 µM) and either xanthine oxidase/hypoxanthine/ 
catalase as a source of superoxide42, reduced cytochrome b543 or a single bolus of reagent H2O2 (100 
µM) (Fig. 2a). For experiments in Fig. 2b, six aliquots of H2O2 (0.5 µM) were added consecutively, 
and the mixture was incubated for 5 min at 25 °C after addition of each aliquot. For experiments in 
Extended Data, fig. 5c, the isomer of 1-MT indicated, epacadostat, NLG919 (all 1 mM, final 
concentration), urate (500 µM), cis-norbixin (130 µM), or the appropriate vehicle was added to 
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rhIDO1 and the reaction started by adding a single bolus of H2O2 (100 µM) together with purified 
Trp (100 µM). For the experiments in Fig. 2b, the concentration of Trp products formed was 
adjusted to account for (i) H2O2-independent generation of cis-WOOH, trans-WOOH, cis-WOH, 
NFK and OIA; and (ii) the cis-WOOH decay observed over 55 min at 25 °C in the presence of 
IDO1/H2O2. For the experiments in Fig. 2c, bolus H2O2 was replaced with H218O2 and O2 with 18O2. 
Following incubation, 5 µL of the reaction mixture were removed and injected directly onto the 
liquid chromatography/tandem mass spectrometry (LC-MS/MS) to determine the concentration of 
cis-WOOH, trans-WOOH, cis-WOH, NFK and the peroxidase product oxyindolylalanine (OIA). 
For experiments in Extended Data, fig. 6b, thiol-blocked IDO1 was generated by treatment with N-
ethylmaleimide (NEM). Specifically, IDO1 (40 µM) was incubated with 100 mM NEM for 10 min 
in the dark. Excess NEM was then removed by centrifuging the reaction mixture in a pre-washed 
3K nanosep centrifugal device (Pall Corporation, USA) at 14,000g for 10 min at 4 °C. The protein 
concentration of the NEM-alkylated IDO1 was then determined by spectrophotometry before use. 
Detection and quantification of Trp oxidation products by LC-MS/MS. Chemical and 
enzymatic reaction mixtures as well as tissue homogenates were analyzed using an Agilent 1290 
UHPLC system connected to an Agilent 6490 triple-quadrupole mass spectrometer equipped with 
an electrospray ionization source operating in positive ion mode. For qualitative analysis, samples 
(5 µL) were separated on a 5 µm Luna C18(2) column (150 x 2.10 mm; Phenomenex) by gradient 
elution using mobile phase A (0.1 % acetic acid in H2O) and mobile phase B (0.1% acetic acid in 
acetonitrile) at 0.2 mL min−1. The gradient consisted of 0-30% mobile phase B from 0- 30 min, 30-
100% mobile phase B from 30-40 min. For quantitative analysis, samples (5 µL) were separated on 
a 5 µm Luna C18(2) column (30 x 2.10 mm; Phenomenex) by gradient elution using the same 
mobile phases as above at 0.15 mL min−1. However, the gradient consisted of 0–5 % mobile phase 
B from 0-6 min, 5-100% mobile phase B from 6-8 min. Mass spectrometer parameters were as 
follows: gas temperature = 250 °C; gas flow = 20 L/min; nebulizer pressure = 35 psi; sheath gas 
heater = 325 °C; sheath gas flow = 12 L/min; capillary voltage = 3,500 V. For full scan studies, the 
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mass spectrometer was set to scan 100-1000 m/z range while for product ion studies the instrument 
was set to capture and fragment the largest ion in the peak. Detection and quantification of Trp 
metabolites was by multiple reaction monitoring (MRM) using the above general mass 
spectrometry parameters with fragmentor voltage at 380 V and cell accelerator voltage at 5 V. In 
each case the largest fragment ion generated by collision-induced dissociation of the [M+H]+ ion 
was used for quantification. Settings for the target analytes were (parent ion → fragment ion); Trp 
(m/z 205 → 146) with collision energy (CE) = 17 V; kynurenine (m/z 209 → 146) with CE = 10 V; 
NFK (m/z 237 → 192) with CE = 5 V; cis-WOOH (m/z 237 → 203) with CE = 5 V; cis-WOH and 
OIA (m/z 221 → 175) with CE = 5 V; 15N2 cis-WOOH (m/z 239 → 205) with CE = 5 V. All 
analytes were quantified against corresponding authentic HPLC-purified standards (prepared in 
HPLC-grade H2O, except for trans-WOOH which was made in H2O:DMSO, 1;1; vol:vol), except 
for 15N2 cis-WOOH that was quantified against HPLC-purified non-labeled cis-WOOH. Data 
acquisition was performed using the Agilent Mass Hunter Data Acquisition software version 
B.06.00 Build 6.0.6025.0 and analysis was performed using Mass Hunter Qualitative Analysis 
version B.06.00 Build 6.0.633.10 Service pack 1. 
NMR spectroscopy studies. One- and two-dimensional NMR spectra were recorded at 300 K 
using a Bruker Avance III 400, 500 or 600 MHz spectrometer. 1H and 13C NMR chemical shifts are 
reported in parts per million (ppm) and are referenced to the residual signal of D2O (4.79 ppm). 
Nuclear Overhauser Effect (NOE) difference experiments were carried out by irradiation of the 
peak of interest and allowing for the development of the NOE signal to form. A blank spectrum was 
obtained by irradiation at a region in the spectrum not containing any peaks. The subsequent NOE 
difference spectrum was obtained by subtracting the blank from the spectrum of interest. 
Detection of 2-chloroethidium as a marker of hypochlorite. Formation of hypochlorite by 
rhIDO1 in the presence of H2O2 was assessed by the conversion of hydroethidine (HE) to 2-
chloroethidium (2-Cl-E+) by LC-MS/MS as described previously44. 
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Detection of hydroperoxides. Hydroperoxides were determined by HPLC with post-column 
chemiluminescence detection using the luminol/microperoxidase method of lipid 
hydroperoxides14,45. Trp-derived hydroperoxides were separated on a Luna C18(2) (150 x 4.6 mm; 
5 µm) column (Phenomenex) using 0.1% acetic acid in H2O at 1 mL min-1. Flow was directed into a 
UV detector set at 230 nm and then subsequently mixed with a reaction solution containing 1 mM 
isoluminol, 2 mg/L microperoxidase in 20% methanol and 19% borate buffer, pH 10 at 1.5 mL min-
1. The flow of the reaction mixture was then directed into a chemiluminescence analyzer (CLD-100; 
Tohoku Electronic Industrial, Miyagi, Japan) with a gain = 1 and attenuation = 8. 
Detection of dityrosine. Following reaction with H2O2, rhIDO1 was separated by size exclusion 
chromatography on a BioSep 3000 (300 x 7.8 mm) column (Phenomenex) using 50 mM potassium 
phosphate buffer pH 6.8 at 1 mL min-1 using an Agilent 1200 quaternary pump. Flow was directed 
into a UV detector set at 214 nm and detection of dityrosines performed on a fluorescence detector 
with excitation set at 325 nm and emission at 410 nm. 
Detection of urate and parabanic acid. Parabanic acid (PA) and urate were determined as 
described previously24. Samples were analyzed using an Agilent 1290 UHPLC system connected to 
an Agilent 6490 triple-quadrupole mass spectrometer equipped with an ESI operating in negative 
ion mode. For analysis, samples (2 µL) were separated on a 5 µm Devosil C30-UG column 
(Nomura Chemical, Tokyo, Japan; 250 mm x 4.6 mm) by isocratic elution using 0.0025 % formic 
acid in H2O at 0.8 mL min−1. Mass spectrometer parameters were as follows: gas temperature = 
290 °C; gas flow = 11 L/min; nebulizer pressure = 60 psi; sheath gas heater = 400 °C; sheath gas 
flow = 12 L/min; capillary voltage = 2,000 V; column compartment = 40 °C. Detection and 
quantification of PA and UA was by multiple reaction monitoring (MRM) using the above general 
mass spectrometry parameters with fragmentor voltage at 380 V and cell accelerator voltage at 5 V. 
Settings for the target analytes were (parent ion → fragment ion); PA (m/z 113 → 42) with CE = 13 
V; UA (m/z 167 → 123) with CE = 13 V. Chromatographic retention times for PA and urate were 
5.8 and 13.0 min, respectively. All analytes were quantified by area comparison with authentic 
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commercial standards. Data acquisition and analysis were performed as described above for 
tryptophan oxidation products. 
Detection and quantification of 1O2. Fluorescence detection of 1O2 by Singlet Oxygen Sensor 
Green (SOSG, 5 mM) was performed in 96-well black-walled plates (Costar) at 25 °C. Briefly, 
SOSG (100 µM) and then H2O2 (100 µM) were added to 2 µM human serum albumin, 1 µM 
rhIDO1, 1 µM rhIDO1 plus 100 µM Trp, or 1 µM rhIDO1 plus 500 µM urate in 100 mM phosphate 
buffer pH 7.4 in the presence of 100 µM DTPA. Fluorescence of SOSG-endoperoxide was then 
detected using the PHERAstar plate-reader (BMG Labtech GmBH, Germany) with excitation and 
emission set at 485 and 520 nm, respectively. Where indicated, rhIDO1 was pre-treated for 30 min 
at 37 °C with 100 mM CORM-A1, 10 µM 2-(N, N-diethylamino)-diazenolate-2-oxide (DEANO) or 
iCORM-A1 prior to exposure to SOSG/H2O2. iCORM-A1 was generated as described previously46. 
1O2 was quantified by the conversion of anthracene-9,10- diyldiethane-2,1-diyl disulfate disodium 
salt (EAS) to its 1O2-specific product (EAS-O2, synthesized as described47). Mixtures of rhIDO1 (2 
µM), EAS (8 mM) ± H2O2 (100 µM) were incubated under aerobic conditions for 5 min at 25 °C 
before the conversion of EAS to EAS-O2 was determined by LC-MS/MS as described below. At the 
concentration used, EAS traps 50% of available 1O248. To quantify cis-WOOH, EAS was replaced 
in these reactions with purified Trp and the hydroperoxide quantified by LC-MS/MS as described 
above. EAS and EAS-O2 were detected as described previously16 with minor modifications. The 
analytes were separated at a flow rate of 0.8 mL min-1 using a Luna C18(2) reverse phase column, 
250 x 4.6 mm, 5 µm (Phenomenex) using 25 mM ammonium formate (mobile phase A) and 
acetonitrile:methanol 7:3 v/v (mobile phase B) with linear gradient of 25% B from 0-15 min, 25-
70% B from 15-16 min, 70% B from 16-25 min, 70-25% B during 1 min and finally equilibrated at 
25% B for 9 min. Ionization of the sample was by ESI in the negative ion mode using the following 
parameters: gas temperature = 290 °C; gas flow = 1 L/min; nebulizer pressure = 20 psi; sheath gas 
heater = 350 °C; sheath gas flow = 11 L/min; capillary voltage = 3,500 V and nozzle voltage = 500 
V. EAS and EAS-O2 were detected by MRM with fragmentor voltage at 380 V and cell accelerator 
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voltage at 5 V using the following transitions m/z 212 → 97 (CE = 10V) and m/z 228 → 212 (CE = 
10V), respectively. Data acquisition and analysis were performed as described above for tryptophan 
oxidation products. 
Phosphorescence corresponding to the 1O2 monomol light emission was monitored with a 
special FLSP 920 photocounting apparatus (Edinburgh Instruments, Edinburgh, UK) suitable for 
emissions in the near-infrared (NIR) region (800-1400 nm), which enabled the monitoring of the 
kinetics of formation and decay of 1O2 at 1270 nm using a detector coupled to a Hamamatsu 
H10330A-45 apparatus (Hamamatsu Photonics K.K., Hamamatsu, Japan) cooled to -60 °C, with the 
applied potential set to -0.8 kV16. In a typical experiment, 50 µM H2O2 was added to D2O in a 
quartz cuvette (4 mm x 10 mm x 30 mm) in the dark and the reaction started by the addition of 1 
µM rhIDO1 in a final volume of 300 µL. Thermal decomposition of DHPNO2 (endoperoxide of 
N,N-di(2,3-dihydroxypropyl)-1,4-naphthalene dipropanamide), which generates high yields of 
1O247, was used as control with monomol light emission recorded at 1270 nm. Where indicated, 
D2O was replaced with H2O, Trp was added after rhIDO1, or the reaction was carried out under 
anaerobic conditions by bubbling the mixture with N2 (99.9%, Air Products). Alternatively, the 
solution of rhIDO1 was bubbled with CO (1,400 ppm/N2, Air Liquide) or NO (99%, Linde) to 
examine the effect of these gaseous molecules on IDO1/H2O2-mediated formation of 1O2. 
Spectrophotometric studies. cis-WOOH stability studies were performed by incubating cis-
WOOH in 100 mM phosphate buffer pH 7.4 at 37 ºC with spectra (190 to 400 nm) recorded 
(Agilent Cary 100) every 5 min for 150 min against a blank of phosphate buffer. UV-Visible light 
emission studies were performed by incubating 3.6 mM cis-WOOH in D2O phosphate buffer (200 
mM) at 72 °C and emission recorded by a FLSP 920 photon counter (Edinburgh Instruments) 
consisting of two UV-Visible Hamamatsu detectors R9110 (190-700nm), maintained at -20 ºC by a 
CO1 thermoelectric cooler (Edinburgh Instruments). The detector used to measure the steady-state 
light emission from cis-WOOH was not preceded by a monochromator, so that light was recorded 
directly from the cuvette source. To trace the cis-WOOH-elicited chemiluminescence spectrum, a 
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second detector was used and its wavelength was determined using a monochromator. 
Dimerization of human recombinant PKG1α . Purified human recombinant wild type and 
cysteine 42 serine mutant PKG1α49 (5 µM) was reduced in an anaerobic chamber (Saffron 
Scientific Equipment, Knaresborough, UK) with 50 mM DTT and buffer exchanged into 10 mM 
HEPES pH 7.4 and 150 mM NaCl immediately prior to oxidation with Trp-derived hydroperoxides. 
Reactions were quenched with non-reducing SDS sample buffer containing 25 mM N-
ethylmaleimide (NEM), then proteins were separated by SDS-PAGE and visualized by colloidal 
Coomassie staining. 
Animals and animal tissue. All experiments involving animals or rodent tissues complied with the 
ethical regulations of, and were approved by, the Animal Ethics Committees of the Garvan Institute 
of Medical Research/St Vincent’s Hospital, the University of Sydney, and the King’s College 
London. For porcine coronary arteries, we sourced freshly isolated adult pig hearts from a local 
abattoir (Wollondilly Abattoir, Picton, Australia). Experiments were carried out double-blinded 
without randomization, and with sample sizes chosen based on previous experiments of similar 
nature6. We used 8-12 weeks old male and female C57BL/6J and Apoe–/– on a C57BL/6J 
background (Animal Resources Centre, Perth, Australia), Ido1−/− on a C57BL/6J background50 and 
C42S PKG1α knock-in mice28 as well as their corresponding C57BL/6N wildtype controls, and 10-
14 weeks old male and female Wistar rats (Animal Resources Centre). Ido1−/− mice were obtained 
from homozygous knock out breeding, while C42S PKG1α knock-in mice were obtained from 
heterozygous breeding using littermate wildtype controls. Ido1–/–Ido2–/– mice were produced by the 
Mouse Engineering Garvan/ABR (MEGA) Facility (Moss Vale and Sydney, Australia) using 
CRISPR/Cas9 gene targeting in C57BL/6J mouse embryos following established molecular and 
animal husbandry techniques51. Two single guide RNAs (sgRNAs) were employed that targeted 
Cas9 to exon 4 of Ido1 (TTCTCTGAGAGCTCGCAGTAGGG, protospacer-associated motif = 
PAM underlined) and exon 4 of Ido2 (CTTGGGACTCCCGCCTATCCTGG). A solution 
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consisting of the two sgRNAs (15 ng µL-1 each) and full length, polyadenylated S. pyogenes Cas9 
mRNA (30 ng µL-1) was prepared and microinjected into the nucleus and cytoplasm of C57BL/6J 
zygotes. Microinjected embryos were cultured overnight and those that underwent cleavage 
introduced into pseudo-pregnant foster mothers. Pups were screened by PCR across the target sites 
and Sanger sequencing of PCR products used to detect mice carrying frame-shift deletions in both 
Ido1 and Ido2. Following backcrossing to C57BL/6 wild-type mice, heterozygous Ido1+/–Ido2+/– 
mice were identified that carried 17bp deletion and a 1bp insertion in exon 4 of Ido1 and Ido2, 
respectively, that were linked on the same copy of chromosome 8. These mice were bred for further 
analysis. For porcine coronary arteries, hearts obtained freshly from the local abattoir were placed 
in ice-cold Krebs-Henseleit buffer, containing 200 U mL-1 penicillin and 200 µg mL-1 streptomycin, 
and transported to the laboratory for isolation of coronary arteries. Rat mesenteric, coronary and 
cerebral arteries were obtained as part of a tissue sharing arrangement from Mr M. Duebbert and Dr 
J. Villanueve (Victor Chang Cardiac Research Institute). Third order mesenteric arteries were taken 
from Wistar rats of mixed age and sex, whilst coronary and cerebral arteries were taken from 
spontaneously hypertensive rats of mixed age and sex. Once collected arteries were placed briefly 
in ice-cold Krebs-Henseleit prior to myography experiments. 
Endotoxemia was induced in 8-12 weeks old male C57B/6J mice (except for experiments 
described in Fig. 4d-f for which C57B/6N control and C42S PKG1α knock-in mice on C57B/6N 
background28 were used) by intra-peritoneal injection of 5-10 mg per kg body weight 
lipopolysaccharide (LPS, 0111:B4, Sigma-Aldrich L4130). 12-16 h after LPS administration, 
anesthesia was induced using isofluorane prior to blood pressure determination or collection of 
arteries. Arteries were collected after cardiac puncture, exsanguination and perfusion using sterile 
phosphate buffered saline. 
For transverse aortic constriction (TAC) studies, size- (30.5 ± 1.9 g) and age-matched (110  
± 1 day) male C57BL/6J mice were randomly assigned to sham or TAC surgery. Mice subjected to 
TAC surgery were placed under anesthesia using isoflurane and an incision made into the thorax 
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exposing the transverse aorta. A 7-0 prolene suture was then placed around the transverse aorta and 
the constriction sized using a 27-gauge needle. Sham operations consisted of passing the suture 
around the transverse aorta and removing without constriction. Mice were sacrificed 21 d post-
surgery with tissues taken for biochemical and qPCR analyses. Left ventricular hypertrophy was 
determined via weighing the left ventricle and normalizing the weight to the length of the left tibia. 
For atherosclerosis studies, male and female 8-12 weeks old Apoe–/– and Apoe–/–Ido1–/– mice 
were fed a Western Diet (SF00-219, Specialty Feeds, Australia) for six months before assessment 
of vascular tone and blood pressure. This diet is based on Harlan Teklad TD88137 Western Diet 
and contains 22% fat and 0.15% cholesterol. 
Blood pressure. Systolic blood pressure (SBP) in lipopolysaccharide-treated C42S PKG1α knock-
in and corresponding wildtype (C57B/6N) mice was determined using micromanometry as 
described previously52, with the following modification. 12 h after administration of 
lipopolysaccharide (5 mg/kg), an incision was made in the neck of anesthesized mice to expose and 
dissect the left carotid artery and right jugular vein from circumferential connective tissues before 
administration of atropine (0.5 mg/kg) into the right jugular vein to inhibit vagal reflex. A 1.2F 
solid-state catheter (4.5 mm electrode spacing; Transonic, USA) was then inserted into the left 
carotid artery to measure SBP in the aorta. After establishing baseline parameters, SBP was 
recorded in response to intravenous (right jugular vein) infusion of purified Trp (8 mM, final blood 
concentration), vehicle control or SNP (1 µM). Each mouse was exposed to Trp, vehicle and SNP 
with a 2 min rest period between each addition, to allow blood pressure to return to baseline. All 
blood pressure experiments were performed double blinded related to genotype. 
Systolic blood pressure in conscious Apoe–/– and Ido1–/–Apoe–/– mice was recorded as 
described previously6, using a computerized, non-invasive tail cuff system (BP 2000 Blood 
Pressure Analysis System, Visitech Systems) that gives results that correlate closely with intra-
arterial measurements53. An initial 10 inflation-deflation cycle was employed for each mouse to set 
amplifier and instrument controls. Subsequently, 10 readings were averaged for a single session 
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value. Systolic blood pressure was recorded before and 1 h after intra-peritoneal administration of 1 
mL 20 mM (1-D-MT) (an IDO1 inhibitor). 
Arterial relaxation studies. After dissection, arteries were placed immediately in ice-cold Krebs-
Henseleit (Sigma-Aldrich K3753, supplemented with 2.5 mM CaCl2, 10 mM EDTA, 2.1 mg mL-1 
sodium bicarbonate and adjusted to pH 7.4), or MOPS buffer (145 mM NaCl, 4.7 mM KCl, 2 mM 
CaCl2, 1.17 mM MgSO4, 2 mM MOPS, 1.2 mM NaH2PO4, 5 mM D-glucose, 2 mM sodium 
pyruvate, 0.02 mM EDTA and 2.75 mM NaOH to adjust pH to 7.4) before further analysis. Isolated 
conduit and resistance arteries were used either immediately after dissection (naïve, LPS-treated or 
6 months Western Diet-fed mice; naïve rats; porcine arteries) or after 48 h incubation at 37 °C in 
M199 media containing 200 U mL-1 penicillin, 200 µg mL-1 streptomycin, and L-NG-nitroarginine 
methyl ester (L-NAME, 100 µM) in the presence or absence of 400 ng mL-1 of recombinant mouse 
interferon-γ (IFNγ) of the relevant species to induce IDO1 expression. Arterial rings were then 
mounted in Krebs-Henseleit buffer onto 25 or 40 µm wires in a multiwire myograph system (Model 
610M, Danish Myo Technology, Aarhus, Denmark). The 25 µm wires allow working with vessels 
as small as ~80 µm inner diameter. To assess microvascular function in the present study, we used 
third order mesenteric arteries of 100-200 µm, taken between the base of the mesenteric arterial 
arcade and the gut wall54. To establish passive tension, aortas were subjected to a length/tension 
protocol as described previously6, whilst resistance arteries were normalized to 90% of the internal 
circumference obtained at 100 mmHg55. Once passive tension was established, arteries were 
stimulated with KCl (60 or 120 mM) and then washed out and allowed to equilibrate to baseline 
tension for 30 min. Arteries were then constricted sub-maximally using ~EC80 norepinephrine or 
U46619. After stable tone was achieved, acetylcholine, purified Trp (8 mM), NFK, kynurenine, or 
‘1O2-exposed Trp’ and its purified products including cis-WOOH were added either as a bolus or in 
a concentration-dependent manner, in the presence or absence of 1-L-MT (1 mM). To negate the 
effects of the endothelium, and where indicated, L-NAME (100 µM) and indomethacin (10 µM) 
were added in the buffer throughout the experiment, or arteries were denuded via luminal perfusion 
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with 100 µL Triton X-100 (0.1% v/v) for 10 s, followed by 100 µL of Krebs-Henseleit buffer. 
Denudation was confirmed by <10% response to acetylcholine (0.1 – 10 µM). At the end of each 
experiment, arteries were stimulated with the endothelium-independent relaxant sodium 
nitroprusside (SNP, 10 µM) and arteries were deemed viable if responses of ≥80% maximal 
relaxation were observed. 
Measurement of arterial H2O2. Arterial H2O2 was measured by the aminotriazole-inhibitable 
catalase activity assay56. Briefly, naïve or IFNγ-treated porcine arterial rings (400 ng mL-1) were 
incubated in the presence or absence of 3-amino-1,2,4-triazole (20 mM) for 48 h at 37 ºC. Arterial 
rings were then washed twice with MOPS buffer, immediately snap frozen in liquid N2, pulverized 
and then homogenized in 1 mL of homogenization buffer (100 mM phosphate buffer pH 7.4 
containing 100 µM EDTA, 100 µM DTPA and Triton X-100, 0.1% v/v) using 3 x 1 min bursts at 
7,000 rpm (Heidolph homogenizer). Homogenates were centrifuged for 15 min at 1,000 g and 4 ºC 
and 40 µL of supernate added to 950 µL of homogenization buffer in a quartz cuvette placed in an 
Agilent Cary 100 spectrophotometer at 25 ºC. Catalase activity was then determined by monitoring 
the decrease in absorbance at 240 nm over 15 min following the addition of H2O2 (10 µL, 20 mM 
final concentration). The amount of H2O2 in the arteries was calculated as the difference in the loss 
of catalase activity between untreated and aminotriazole-treated tissue, and expressed per min and 
mg protein. Protein quantification in samples was determined by using bicinchoninic acid assay 
(BCA) as per manufacturer’s instructions. 
Detection of labeled cis-WOOH in porcine arteries. Left anterior descending coronary arteries 
were dissected from porcine hearts. Arteries were cut into 2 mm wide rings and placed in M199 
media containing penicillin and streptomycin, Fungizone (Amphotericin B 2.5 µg mL-1; Invitrogen) 
and L-NAME (100 µM). After incubation for 48 h at 37 °C in 95% air 5% CO2 in the absence or 
presence of 200 or 400 ng mL-1 recombinant porcine IFNγ, rings were washed twice with MOPS 
buffer containing DTPA (100 µM) and NEM (1 mM), and then incubated for 60 min at 37 °C in 
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95% air 5% CO2 in MOPS buffer containing DTPA (100 µM), NEM (1 mM), L-NAME (100 µM) 
and indomethacin (10 µM). After addition of norepinephrine (3 µM final concentration), rings were 
incubated for further 20 min before addition of 15N2 Trp (6 mM). After 6 min, rings were removed 
from the buffer and snap frozen in liquid N2. Rings were then pulverized on liquid N2 using mortar 
and pestle, followed by addition of 2 mL of ice-cold HPLC grade H2O containing 2x protease 
inhibitor cocktail, NEM (1 mM) and trans-WOOH (10 µM, as internal standard), and homogenized 
on ice using 5 x 1 min bursts at 7,000 rpm (Heidolph homogenizer). Homogenates were then 
centrifuged at 3,220 x g for 10 min at 4 °C, the supernate removed and re-centrifuged for further 10 
min at 17,000 x g at 4 °C. Five microliters of supernate was then subjected to LC-MS/MS to detect 
15N2 cis-WOOH. Protein quantification in samples was determined by using the BCA assay as per 
manufacturer’s instructions. 
Detection of parabanic acid in porcine arteries. Left anterior descending coronary arteries were 
dissected from porcine hearts. Arteries were cut into 2 mm wide rings and placed in M199 media 
containing penicillin, streptomycin, Fungizone and L-NAME as described above. After incubation 
for 51 h at 37 °C in 95% air 5% CO2 in the absence or presence of recombinant porcine IFNγ (400 
ng mL-1), rings were washed twice with MOPS buffer containing DTPA (100 µM) and then 
incubated for 8 h at 37 °C in 95% air 5% CO2 in MOPS buffer containing DTPA (100 µM), L-
NAME (100 µM) and indomethacin (10 µM). After addition of norepinephrine (3 µM final 
concentration), rings were incubated for further 20 min, washed twice with 100 mM phosphate 
buffer pH 7.4, before addition of 100 mM phosphate buffer pH 7.4 containing 500 µM urate, After 
5 min, purified Trp was added (8 mM) and rings were incubated for a further 5 min before being 
removed, blotted dry, weighed and snap frozen in liquid N2. Rings were pulverized on liquid N2 
using mortar and pestle, followed by addition of 2 mL ice-cold 100 mM phosphate buffer pH 7.4 
containing 2x protease inhibitor cocktail, and then homogenized on ice using 5 x 1 min bursts at 
7,000 rpm (Heidolph homogenizer). Homogenates were then centrifuged at 3,220 x g for 10 min at 
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4 °C, the supernate removed and re-centrifuged for further 10 min at 17,000 x g at 4 °C. Two 
microliters of supernate was then subjected to LC-MS/MS to detect parabanic acid. 
SDS PAGE, silver stain and carbonyl detection. rhIDO1 (2 µM) and H2O2 (100 µM) were 
incubated in the absence and presence of Trp (100 µM) and/or 5,5-dimethyl-1-pyrroline N-oxide 
(DMPO, 20 mM) and equal amounts of the reaction mixtures then subjected to SDS-PAGE using 
10% poly-acrylamide gels and SeeBlueTM Plus2 pre-stained protein standard as molecular mass 
standards. Electrophoresis was performed at 200 V for 45-60 min and separated proteins were 
visualized by silver staining. Alternatively, protein carbonyls were detected after derivatization with 
dinitrophenylhydrazine using the OxyBlot kit (Millipore). 
RT-PCR for IDO1 detection in transaortic constriction tissues. Total RNA was extracted from 
the left ventricle of sham- and TAC-operated mice, and the left ventricle isolated from a wildtype 
mouse and exposed to IFNγ for 48 h (positive control for IDO1 expression), using TRIzol reagent. 
Reverse transcription was carried out using the Superscript IV first strand cDNA synthesis system. 
Quantitative real-time PCR was performed on a LightCycler® 480 instrument (Roche) using the 
SensiFASTTMSYBR® NO-ROX kit (Bioline) as per manufacturer’s protocol. Data were normalized 
to housekeeping gene Hprt using the comparative CT method57. Melt curve analysis was used to 
confirm that all PCR reactions produced a single product. The primers (forward/reverse) used in 
real-time PCR were: mldo1: 5'-CCCACACTGAGCACGGACGG/ 5'-
TTGCGGGGCAGCACCTTTCG-3; Hprt: 5’-GCTTTCCCTGGTTAAGCAGTACA/5’-
CAAACTTGTCTGGAATTTCAAATC. 
Western blotting. Dimerization of PKG1α was assessed by Western blot analysis as described 
previously28 with minor modifications. For arterial tissue, aortas or mesenteric arteries isolated from 
mice were placed in MOPS buffer, incubated at 37 °C for 20 min, stimulated with ~EC80 
norepinephrine for 20 min and then treated with a bolus of HPLC-purified Trp (8 mM) or 
metabolites thereof (1 mM), H2O2 (positive control, data not shown), or vehicle for 3 min. Arteries 
	 41 
were snap frozen and placed in 10 µL NEM (100 mM) then pulverized on liquid N2, suspended in 
RIPA buffer (150 mM NaCl, 50 mM Tris-HCl, 5 mM EDTA, 1% sodium deoxycholate, 0.1% SDS, 
1% Triton X-100) supplemented with protease inhibitors and then subjected to two cycles of 
freezing (in liquid N2) and thawing. Non-reducing SDS sample buffer was then added to 
homogenates, the samples heated at 90 °C for 10 min, and then centrifuged at 11,000 x g for 5 min. 
The resulting supernate was removed and centrifuged again for 5 min at 11,000 x g, after which an 
equal volume of supernate was loaded onto 10% poly-acrylamide gels. Electrophoresis was 
performed at 200 V for 1 h and separated proteins were transferred onto nitrocellulose membranes 
at 20-25 V in a stepwise manner for 7 min using the iBlot 2 Dry Blotting System (ThermoFisher 
Scientific). Blotted membranes were blocked in 10% (w/v) skim milk powder with 0.1% (v/v) 
Tween 20 in Tris-buffered saline for 1 h at room temperature. Blocked membranes were then 
probed overnight at 4 °C with rabbit polyclonal anti-PKG antibody (1:1,000 dilution, v/v, ENZO 
Life Sciences ADI-KAP-PK005) in 10% (w/v) skim milk and Tween 20-containing Tris-buffered 
saline, followed by 1 h incubation with horseradish peroxidase-conjugated IgG (1:2,000 dilution, 
v/v, Dako P0448) at room temperature in 10% skim milk and 0.1% Tween 20 in Tris-buffered 
saline. Protein bands were detected by enhanced chemiluminescence according to the 
manufacturer’s instructions (ECL detection reagent and Hyperfilm ECL, GE Healthcare 
BioSciences) and analyzed by densitometry using the Image Studio Lite (LI-COR). To examine the 
effects of cis-WOOH on PKG1α dimerization in arteries of Ido1–/– mice, the above method was 
modified slightly. Samples were not heated or subjected to freeze thawing. Samples were run on 4-
20% polyacrylamide gels (Mini-PROTEAN TGX, Bio-Rad), electrophoresis was performed at 200 
V for 1 h and separated proteins were transferred onto 0.2 µm nitrocellulose membranes (Bio-Rad) 
at 2.5 A for 10 min using the Trans-Blot Turbo Blotting System (Bio-Rad). Immunoblotting was 
then performed as described above. 
For human aortic vascular smooth muscle cells (HASMC, Lonza CC-2571), cells (passage 
numbers 3-5) were cultured in Smooth Muscle Growth Medium-2 with BulletKit (SmGM, Lonza), 
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grown to confluence in 12-well plates and incubated for 72 h in SmGM in the absence and presence 
of 100 ng mL-1 recombinant human IFNγ to induce IDO1 expression58. Cells were authenticated by 
Lonza and tested (negative) for mycoplasma contamination. Media was then replaced with Hanks 
Buffered Saline Solution for 2 h prior to pre-treatment of the cells with or without 10 µM 
epacadostat or vehicle (0.1% DMSO) for 30 min. HASMC were then treated for 5 min with purified 
Trp (8 mM) and/or H2O2 at the concentration indicated, washed twice with cold phosphate buffered 
saline and lysed directly into non-reducing SDS sample buffer containing 100 mM NEM. Samples 
were centrifuged at 11,000 x g for 10 min and 10 µL of supernate loaded onto 4-20% 
polyacrylamide gels (Mini-PROTEAN TGX, Bio-Rad). Electrophoresis was performed at 200 V for 
1 h and separated proteins were transferred onto 0.2 µm nitrocellulose membranes (Bio-Rad) at 2.5 
A for 10 min using the Trans-Blot Turbo Blotting System (Bio-Rad). Membranes were blocked in 
10% (w/v) skim milk powder with 0.1% (v/v) Tween 20 in Tris-buffered saline for 1 h at room 
temperature. Blocked membranes were probed overnight at 4 °C with rabbit polyclonal anti-PKG 
antibody (1:1,000 dilution, v/v) or rabbit monoclonal anti-IDO1 (1:5,000 dilution, v/v, Cell 
Signalling 86630) in 10% (w/v) skim milk and Tween 20-containing Tris-buffered saline. 
Following this, membranes were incubated with horseradish peroxidase-conjugated IgG (1:2000 
dilution, v/v) at room temperature in 10% skim milk and 0.1% Tween 20 in Tris-buffered saline for 
1 h. Protein bands were detected and analyzed as described above. 
Immunohistochemistry and atherosclerosis lesion assessment. Expression of IDO1 protein in 
atherosclerotic lesions from mouse thoracic aortas and kidney was assessed using a rabbit 
polyclonal antibody to mouse Ido1 (KR101, TransGenic Inc., 1:200, v/v)6. Rabbit Immunoglobin 
Fraction (X0936, Dako) served as isotype control. Diaminobenzidine chromogen (K3467, Dako) 
was used for color development. Sections were counter-stained in hematoxylin. 
Statistics and reproducibility. Where indicated, data are shown as means ± s.e.m. Differences 
between experimental groups were analyzed by the Kruskal-Wallis test with Dunn’s post hoc test 
for multiple groups and the Mann-Whitney rank sum test for comparison between two groups. 
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Dose-response curves were compared by two-way ANOVA for repeated measures with Šidák post 
hoc test, or by one-way ANOVA of maximal relaxation with Dunnett’s post hoc test. P-values 
≤0.05 were considered significant for all statistical tests. The reproducibility of the data are 
demonstrated by the number of independent experiments performed, as detailed in Supplementary 
Information, ‘Main figure data sample size’ (for main figures) and figure legends (Extended Data). 
The data that support the findings of this study are available from the corresponding author upon 
reasonable request. 
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Extended Data, table 1. 1H and 13C NMR data for purified Peaks 2, 4, 5 and 6 in D2O 
(calibrated to 4.79 ppm) 
Extended Data, figure legends 
Extended Data, figure 1. Only Peak 6 induces arterial relaxation in resistance and conduit 
arteries from different vascular beds and species. a, Lack of relaxation of pre-constricted 
abdominal aortas from wildtype mice without (naïve) and with interferon-γ (IFNγ) pretreatment, 
and with intact (+EC) or denuded endothelium (-EC), in response to purified Kyn (n=9) or N-
formylkynurenine (NFK) (n=4). b, Representative myography traces of purified Trp-induced 
relaxation of IFNγ-pretreated abdominal arteries from: wildtype (Ido1+/+) mice without (top) and 
with the IDO1 inhibitor 1-L-methyltryptophan (1-L-MT) (middle); and Ido1–/– mice (bottom). c, 
Relaxation of pre-constricted abdominal aortas from Ido1+/+ or Ido1–/– (n=6) mice in response to 
vehicle (open bars) or purified Trp (filled bars) ± 1-L-MT, with IDO1 expression induced ex vivo by 
IFNγ-pretreatment or in vivo by lipopolysaccharide (LPS) treatment of mice. d, Concentration-
dependent arterial relaxation of norepinephrine (NE) pre-constricted, endothelium-denuded mouse 
abdominal aorta by purified Peaks 1-6. e-i, Peak 6 concentration-dependent arterial relaxation in 
endothelium-denuded murine (e), rat (f, g, h), and porcine (i) arteries pre-constricted with NE (e, f) 
or the thromboxane A2 receptor agonist U46619 (g, h, i). Data show mean ± s.e.m. of n=18 and 6 
(c,vehicle treatment for IFNγ and LPS, respectively), n=5 (c, Trp without IFNγ), n=10 and 6 (c, Trp 
addition for IFNγ and LPS, respectively), n=5 and 6 (c, Trp addition in presence of 1-MT for IFNγ 
and LPS, respectively), n=6 (c, Trp addition in Ido1–/– for IFNγ and LPS, respectively) n=4 (d-h) 
and n=5 (i) independent experiments, with type and diameter range of the arteries indicated. Data 
shown in b are representative of the data shown in c. 
Extended Data, figure 2. Characterization of reaction products formed during 1O2-mediated 
oxidation of tryptophan. a, LC-MS chromatogram of reaction products from the oxidation of L-
tryptophan by Rose Bengal/O2/light showing molecular ions, [M+H]+ for peaks 1-8. b, Tandem 
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mass (MS/MS) spectra of precursor ions with mass-to-charge (m/z) ratio of 221 (Peaks 2 and 4) and 
237 (Peaks 5 and 6). c, HPLC chromatograms of reaction products from L-tryptophan oxidation by 
Rose Bengal/O2/light showing retention times of Peaks 1-6 monitored at 230 nm and their 
corresponding post-column chemiluminescence (CL) signals. d, HPLC-UV and CL chromatograms 
of Peaks 5 and 6 after their chemical reduction with sodium borohydride. Data shown are 
representative of n=6 (a) and 2 independent experiments (b-d). 
Extended Data, figure 3. Identification of reaction products formed during 1O2-mediated 
oxidation of tryptophan. a, Comparison of molecular ions and fragmentation pattern of Peaks 2 
and 4 with those of chemically reduced Peaks 5 and 6. b, Comparison of 1H NMR spectra of Peaks 
2 and 4 (top) with those of chemically reduced Peaks 5 and 6 (bottom). c, d, 1H NMR spectra of 
irradiated Peak 2 (g) in CD3OD/D2O and Peak 4 (h) in CD3OD (top spectra). The arrow indicates 
the spectral peak irradiated. The bottom spectra show the respective NOE differential spectra of the 
irradiated peak with the dashed oval indicating anti-phase NOE interaction. e, f, Structures of Peak 
2 (trans-WOH) and Peak 4 (cis-WOH) showing irradiated proton H8a and indication of the NOE 
correlation. Data shown are representative of n=2 (a, b) and 1 separate experiments (c-d). 
Extended Data, figure 4. Conversion of cis-WOOH to N-formylkynurenine (NFK). a, Spectral 
changes during incubation of cis-WOOH in phosphate buffer at 37 °C measured in 15 min intervals. 
Arrows indicate increase (↑) and left shift (←) in absorbance, while inset shows spectrum of 
authentic NFK. b, 1H NMR spectra of cis-WOOH in D2O and 25 °C recorded at 5 min (top) and 
360 min (middle). Arrows indicate increases in spectral peaks at 4.1, 7.6, 7.9, 8.1 and 8.3 ppm. 
Bottom shows 1H NMR spectra of authentic NFK. c, Time-dependent loss of cis-WOOH and 
formation of NFK during incubation of cis-WOOH at 37 °C in the presence of 
diethylenetriaminepentaacetic acid, as assessed by LC-MS/MS. d, Light emission upon addition of 
cis-WOOH in D2O phosphate buffer at 72 °C (left), with corresponding chemiluminescence spectra 
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(right). e, Proposed mechanism of formation of cis-WOOH from 1O2-mediated oxidation of Trp. 
Data shown are representative spectra of 1 (b, c) and 2 separate experiments (a, d). 
Extended Data, figure 5. Role of 1O2 in IDO1/H2O2-mediated oxidation of Trp to cis-WOOH 
and Trp-induced arterial relaxation. a, LC-MS/MS analysis of cis-WOOH (circles) and trans-
WOOH (squares) following exposure of L-tryptophan to Rose Bengal/O2/light for the time 
indicated. b, Formation of cis- and trans-WOOH during oxidation of Trp by Rose Bengal/O2/light 
(RB) and IDO1/H2O2. c, Inhibition of IDO1/H2O2-mediated cis-WOOH formation by different 
pharmacological IDO1 inhibitors (all tested at 1 mM), with results expressed as the percentage of 
cis-WOOH formed in presence versus absence of inhibitor (control). d, IDO1-mediated formation 
of Trp-derived metabolites with bolus addition of H2O2 in Ar- (black) or O2-flushed buffer (grey). 
Metabolite yield is expressed as percentage of that observed in the reaction under air. e, Trp-
induced relaxation of mouse abdominal aortas pretreated with mouse recombinant interferon-γ 
(IFNγ) and vehicle (Ctrl), polyethylene glycol (PEG) or PEG-catalase (PEG-Cat). f, Fluorescence 
changes upon addition of H2O2 to Singlet Oxygen Sensor Green (SOSG) in the presence of human 
serum albumin (HSA, red), or IDO1 without (green) and with Trp (black). g, LC-MS/MS 
chromatograms of the reaction mixture of IDO1 and anthracene-9,10-diyldiethane-2,1-diyl disulfate 
disodium salt (EAS) after incubation without (top) and with H2O2 (bottom). h, Fluorescence 
changes upon addition of H2O2 to SOSG in the presence of either IDO1 ± inactivated carbon 
monoxide-releasing molecule-A1 (iCORM-A1, green), IDO1 pre-treated with CORM-A1 (red), 
urate (blue), or DEANO (black). i) Near infrared (NIR) emission upon addition to H2O2 of IDO1 
pre-treated with CO gas. j, Formation of cis- and trans-WOOH during oxidation of Trp by 
horseradish peroxidase (HRP)/H2O2, myeloperoxidase (MPO)/H2O2 and purified IDO2/H2O2. k, 
Trp-induced relaxation of pre-constricted abdominal aortas from wildtype (WT), Ido1–/– or Ido1–/–
Ido2–/– mice. l, Effect of cis-norbixin (100 µM) on relaxation of IFNγ-pretreated mouse abdominal 
aorta induced by Trp or the nitric oxide donor sodium 2-(N, N-diethylamino)-diazenolate-2-oxide 
(DEANO). In b, c, and f, reactions were initiated by the addition of H2O2/Trp and the mixtures 
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incubated for 5-15 min at 25 °C before products were quantified by LC-MS/MS. Data show mean ± 
s.e.m. of n=3 (a-d, j, k, relaxation to DEANO in l) or n=5 (e, relaxation to Trp in l) independent 
experiments, or representative data (f, h) of 3 independent experiments. 1-MT, 1-methyltryptophan; 
Ep, epacadostat; NLG, NLG919; RB, Rose Bengal. *p=0.05 compared with absence of inhibitor (c) 
or air control (d) (One-tailed Mann-Whitney). The specific p-values indicated were derived using a 
one-sided Mann-Whitney (l) and a Kruskal-Wallis test with Dunn’s multiple comparison (e). 
Extended Data, figure 6. Mechanism of 1O2 formation by IDO1/H2O2. Known mechanisms of 
1O2 generation by dark reactions in biochemical systems involve superoxide radical anion, thiyl 
radicals, hypochlorite plus H2O2, energy transfer from excited triplet carbonyls, or peroxy 
radicals.25 For all reactions, IDO1 (2 or 4 µM) was incubated for 5 min (h for 30 min) at 25 °C in 
the presence of 100 µM diethylenetriaminepentaacetic acid, 100 µM Trp and the scavengers and 
substrates indicated, with the reaction being initiated by addition of a 50-fold molar excess of H2O2. 
cis-WOOH was then quantified by LC-MS/MS. a, b, Lack of effect of Cu/Zn superoxide dismutase 
(SOD) and N-ethylmaleimide (NEM) on cis-WOOH formation by IDO1/H2O2, suggesting that 
superoxide and thiyl radicals are unlikely involved in 1O2 generation by IDO1/H2O2. Results in a 
are expressed as the percentage of cis-WOOH formed in the presence versus absence (control) of 
100 U SOD, whereas in b results are expressed as percentage of Trp converted to cis-WOOH. c, 
Lack of effect of IDO1/H2O2 on conversion of hydroethidine (HE) to 2-chloroethidium (2-Cl-E+) in 
phosphate buffered saline (PBS), as determined by LC-MS/MS, ruling out the involvement of 
hypochlorite. d, Scavengers of excited carbonyls (sorbate) modestly and scavengers of oxygen-
centered radicals (5,5-dimethyl-1-pyrroline N-oxide; DMPO) substantially attenuate formation of 
cis-WOOH by IDO1/H2O2. e, Support for the implied involvement of protein peroxy radicals by the 
formation of IDO1 fragments (double arrow) and dimers (arrow) upon reaction of IDO1 with H2O2 
in the absence or presence of Trp or DMPO as assessed by SDS-PAGE under non-reducing 
conditions and visualization of proteins by silver stain. f, g, Formation of IDO1-associated 
dityrosine-specific fluorescence and IDO1 hydroperoxides during exposure of IDO1 to H2O2 in 100 
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mM phosphate buffer in the absence of Trp ± DMPO (f) or ± ascorbate (Asc, g). Reaction mixtures 
were subjected to size exclusion chromatography with HPLC-UV214nm (left) and (f) fluorescence or 
(g) post-column chemiluminescence (CL) detection (right). Ascorbate was used as a reductant for 
protein hydroperoxides. h, IDO1/H2O2-mediated conversion of EAS (1 mM) to EAS endoperoxide 
(EAS-O2) in the absence and presence of DMPO. Inhibition of formation of dityrosine fluorescence 
and conversion of EAS to EAS-O2 by DMSO suggests59 that the reaction of IDO1 with H2O2 yields 
a porphyrin radical, which delocalizes to aromatic amino acid residues of IDO1, most likely a Tyr 
residue. The resulting amino acid-derived phenoxy radical may then engage in dityrosine formation, 
β-scission and/or fragmentation reactions, as well as formation of protein peroxy radicals (Extended 
Data, figure 9a), in accordance with known chemistry60. Consistent with this possibility, reaction of 
IDO1 with H2O2 also generated protein carbonyls (i), the formation of which was inhibited by Trp 
and DMPO. Following reaction, IDO1 was denatured with 6% SDS in the presence of 
dinitrophenylhydrazine (DNPH) before protein was transferred onto nitrocellulose membrane, and 
carbonyls detected using anti-DNPH antibody. Qualitative data shown are representative of 2-3 
separate experiments. Quantitative data shown are mean ± s.e.m. of 3 independent experiments. 
*P≤0.05 (Mann-Whitney, one-sided) compared with absence of inhibitors (a, d). 
Extended Data, figure 7. Role of protein kinase G1α  (PKG1α) in arterial relaxation by 
IDO1/cis-WOOH. a, b Concentration-response curves to cis-WOOH after pre-treatment of 
denuded mouse abdominal aortas with vehicle (filled squares) or the competitive cGMP PKG 
inhibitor RP-8CPT-cGMP (a, open squares), or the competitive ATP binding PKG inhibitor 
KT5283 (b, open squares). c, Relaxation of pre-constricted mouse mesenteric resistance arteries 
from lipopolysaccharide-treated wildtype (black) and PKG1α C42S knock-in mice (grey) by the 
nitric oxide donor sodium 2-(N, N-diethylamino)-diazenolate-2-oxide (DEANO) (n=4 for both 
genotypes). d, e, IDO activity in kidney homogenate (d) or plasma (e) obtained from wildtype 
(WT) or PKG1α C42S knock-in (KI) mice after treatment with lipopolysaccharide. f, Dimerization 
of PKG1α in human smooth muscle cells induced by Trp, 1 µM H2O2 or both, in the presence (+) 
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or absence (–) of the IDO1 inhibitor epacadostat (n=5). Cells were pre-treated with (+) or without 
(–) 100 ng mL-1 recombinant human interferon-γ (IFNγ) for 72 h. Data show mean ± s.e.m. of 5 (a, 
f), 4 (b, c, e) or 3-4 (d) independent experiments. *p≤0.05 using repeated measures 2-way ANOVA 
with Šidák multiple comparison post-hoc test (a-c), Kruskal Wallis with Dunn’s test (f). NS, not 
significant (Mann-Whitney). 
Extended Data, figure 8. Role of IDO1 in pressure-overload related cardiac pathophysiology 
and experimental atherosclerosis. a, Cardiac expression of Ido1 mRNA after sham and transverse 
aortic constriction (TAC) for 21 days (n=3 mice per treatment), with IFNγ-treated hearts (n=2 mice) 
as positive control. Inset: increase in ventricle weight-to-tibia length ratio as evidence for TAC-
induced cardiac hypertrophy. b, c, IDO1 staining (brown color) of (b) atherosclerotic lesions in 
thoracic aorta and (c) resistance vessel in kidney of Apoe–/– (top, representative of n=1 and 4 mice 
for b and c, respectively) and Apoe–/–Ido1–/– mice (bottom, representative of n=2 and 3 mice for b 
and c, respectively) after six months of Western Diet (WD). Middle panels represent rabbit negative 
immunoglobulin fraction control staining of (b) atherosclerotic lesions in thoracic aorta 
(representative of n=1 mouse) and (c) resistance vessels in kidney (representative of n=4 animals) 
of Apoe–/– mice after six months of Western Diet (WD). For each animal, sections were taken in 
duplicate. Magnification 60x (b) and 20x (c). Arrow heads (c) indicate microvessels. d, Trp-
induced relaxation of pre-constricted, atherosclerotic lesion-containing aortic rings isolated from 
Apoe–/– and Apoe–/–Ido1–/– mice in the presence or absence of IDO1 inhibitor 1-methyltryptophan 
(1-MT) after six months of WD. e, Systolic blood pressure (SBP) of Apoe–/– and Apoe–/–Ido1–/– mice 
before (−) and after (+) administration of 1-D-MT. The specific p-values indicated were derived a 
Kruskal-Wallis test with Dunn’s multiple comparisons (d, e). 
Extended Data, figure 9. a, Proposed mechanism for formation of 1O2 by IDO1 plus H2O2. 
Reaction of Fe3+-heme IDO1 with H2O2 results in formation of the two-electron oxidized form, 
compound I, consisting of a Fe4+=O iron center and a porphyrin cation radical (not shown). The 
	 53 
latter is transferred to an amino acid side chain of IDO1, such as Trp (not shown) or, more likely, 
Tyr such as Y126 or Y353 that are close to the active site heme in IDO161. The IDO1 tyrosyl 
radical may then engage in the formation of fluorescent di-tyrosine crosslinks or H-abstraction 
reactions leading to protein fragmentation according to established pathways60. Alternatively, a 
resonance form of the IDO1 tyrosyl radical may add to molecular oxygen, resulting in the formation 
of a quinone peroxy radical at the para position (e.g., shown on R1-Tyr-Rs) or the ortho position 
(e.g., shown on R6-Tyr-R7). The resulting intermediate quinone peroxy radical may then participate 
in inter- or intra-residue peroxy radical combination, the latter subsequent to additional H-
abstraction and oxidation reactions and formation of a putative intra-residue di-peroxy radical. For 
inter-residue peroxy radical combination to occur it is hypothesized that IDO1’s heme catalyzes the 
decomposition of the hydroperoxide to an alkoxy radical. In the scheme, this reaction is combined 
with oxygen addition to the alpha carbon radical. The resulting tetroxides will decay with release of 
1O2 according to the Russell Mechanism26. The observed stereospecific formation of cis-WOOH by 
IDO1/H2O2/L-Trp suggests formation of 1O2 close to the active site heme rather than release into 
the bulk phase, and may therefore be more consistent with the intra-residue peroxy radical 
combination pathway. For clarity – the R1-R7 labels represent the continuation of the peptide 
backbone. In the case of the inter-residue peroxy radical combination it is envisioned that peroxy 
radicals on two different Tyr residues within the same IDO1 molecule combine. b, Chemical 
synthesis of epacadostat. 
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